Blink index as a response predictor of blepharospasm to botulinum neurotoxin-A treatment

被引:9
|
作者
Jang, Jeongkyeong [1 ]
Lew, Helen [1 ]
机构
[1] CHA Univ, Dept Ophthalmol, Coll Med, CHA Bundang Med Ctr, 59 Yatap Ro, Seongnam 13496, South Korea
来源
BRAIN AND BEHAVIOR | 2021年 / 11卷 / 11期
关键词
blepharospasm; blink index; blink profile; botulinum neurotoxin-A; HEMIFACIAL SPASM; TOXIN;
D O I
10.1002/brb3.2374
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Purpose We investigated the blink profiles and blink index using ocular surface interferometer in the patients with blepharospasm (BSP) and identified points to consider predictive factor after BSP treatment. Methods In total, 117 eyelids of 59 elderly patients and 20 eyelids of 10 age-matched control group were studied. All BSP patients applied botulinum toxin-A (BoNT-A) injection for treatment of BSP. An ocular surface interferometer (LipiView; TearScience, Morrisville, NC, USA) was used to measure blink profile and blink index; total and incomplete blinks/20 s, and the partial blink ratio (PBR). Eyelid blink time (including lid closing time, closure time, lid opening time), interblink times (IBT), closing speeds (OS), and opening speeds (OS) were analyzed using 600 blinks recorded over 20 s. Results Total blink rate was significantly higher in BSP patients compared to the age-matched control group (p = .029) but other time-related and speed-related index including interpalpebral fissure, PBR, blink time, closure time (CT), interblink time, CS, and OS were not significantly different. In the responder of BSP patients, the average age was higher, CT was shorter, CS was faster than nonresponder (age; p = .016, CT; p < .001, CS; p = .042). Conclusion The blink index by analyzing the blink profile using ocular surface interferometer, and this blink index may be used as a predictive factor for evaluating the clinical response after BoNT-A injection in blepharospasm patients.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Efficacy of Botulinum Neurotoxin in the Treatment of Blepharospasm and Hemifacial Spasm
    Boukadir, Chahrazad
    Khalef, Sadek
    Khedoud, Wahiba Amer El
    TOXICON, 2024, 237 : 15 - 15
  • [2] BOTULINUM NEUROTOXIN-A THERAPY IN MIGRAINE
    Tajti Janos
    Szok Delia
    Tuka Bernadett
    Csati Anett
    Kuris Aniko
    Majlath Zsofia
    Lukacs Melinda
    Vecsei Laszlo
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2012, 65 (3-4): : 77 - 82
  • [3] Botulinum neurotoxin-A in idiopathic chondrolysis: a report of two cases
    Khoshhal, Khalid I.
    Awaad, Yasser
    Abbak, Alshahid A.
    JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B, 2014, 23 (05): : 441 - 446
  • [4] Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
    Bar-On, Lynn
    Aertbelien, Erwin
    Van Campenhout, Anja
    Molenaers, Guy
    Desloovere, Kaat
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [5] Treatment of blepharospasm with botulinum neurotoxin type A: long-term results
    Calace, P
    Cortese, G
    Piscopo, R
    Della Volpe, G
    Gagliardi, V
    Magli, A
    De Berardinis, T
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2003, 13 (04) : 331 - 336
  • [6] Tear osmolarity, dry eye syndrome, blepharospasm and botulinum neurotoxin
    Girard, B.
    Sauveur, G. de Saint
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (10): : 1553 - 1559
  • [7] Botulinum Neurotoxin-A for Treatment of Refractory Neck Pain: A Randomized, Double-Blind Study
    Miller, Diana
    Richardson, Diana
    Eisa, Mahmood
    Bajwa, Rizma Jalees
    Jabbari, Bahman
    PAIN MEDICINE, 2009, 10 (06) : 1012 - 1017
  • [8] Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication
    Wenninger, Fiona Carolin
    Wabbels, Bettina
    TOXINS, 2022, 14 (11)
  • [9] Botulinum toxin treatment of hemifacial spasm and blepharospasm: Objective response evaluation
    Thussu, A
    Barman, CR
    Prabhakar, S
    NEUROLOGY INDIA, 1999, 47 (03) : 206 - 209
  • [10] Botulinum toxin type a purified neurotoxin complex for the treatment of blepharospasm: A dose-response study measuring eyelid force
    Iwashige, H
    Nemeto, Y
    Takahashi, H
    Maruo, T
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1995, 39 (04) : 424 - 431